Pharmaceutical

Tenpoint raises funds to develop cell therapies for vision loss

Tenpoint Therapeutics has raised Series A funds of $70m for developing engineered cell-based therapies to reverse vision loss.

Jul 13, 2023 - 20:00
Tenpoint raises funds to develop cell therapies for vision loss
Tenpoint Therapeutics has raised Series A funds of $70m for developing engineered cell-based therapies to reverse vision loss.
Read the original article

Tags:

Previous Article

Roche eyes alternate mode of administration for Ocrevus in MS

Next Article

FDA accepts BeiGene’s sNDA for follicular lymphoma therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Abdera raises funds to advance radiopharmaceuticals to treat cancer

Abdera raises funds to advance radiopharmaceuticals to ...

Apr 20, 2023

STAT+: Remote patient monitoring helped manage hypertension better, but at a higher cost

STAT+: Remote patient monitoring helped manage hyperten...

Nov 7, 2023

STAT+: More hospital pharmacists are rationing drugs due to increasing shortages

STAT+: More hospital pharmacists are rationing drugs du...

Aug 11, 2023